Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes

PURPOSE: Malignancy-related hypercalcemia (MRH) is associated with a dismal prognosis. The widespread use of bisphosphonates (BPs), availability of more effective drugs in cancer treatment, and improvement in supportive care might have attenuated its impact. PATIENTS AND METHODS: To assess overall s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Ricardo Emanuel de Oliveira, Perez Mak, Milena, Alves, Michel Fabiano Silva, Piotto, Gustavo Henrique Munhoz, Takahashi, Tiago Kenji, Gomes da Fonseca, Leonardo, Silvino, Marina Cavalcanti Maroja, Hoff, Paulo Marcelo, de Castro, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735968/
https://www.ncbi.nlm.nih.gov/pubmed/29244985
http://dx.doi.org/10.1200/JGO.2016.006890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735968/
https://www.ncbi.nlm.nih.gov/pubmed/29244985
http://dx.doi.org/10.1200/JGO.2016.006890

Ejemplares similares